Shane Kovacs - 06 Apr 2023 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CH. OPERATING & FINANCIAL OFF.
Signature
/s/ John B. Moriarty, Jr., Attorney-in-Fact
Issuer symbol
OLMA
Transactions as of
06 Apr 2023
Transactions value $
$0
Form type
4
Filing time
07 Apr 2023, 16:30:16
Previous filing
02 Feb 2023
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Purchase +10K +2.59% 396K 06 Apr 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average purchase price for the transaction reported was $3.4173, and the range of prices were between $3.375 and $3.42. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.
F2 Includes 5,000 shares acquired under the issuer's Employee Stock Purchase Plan.